Avior Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21
| Closed | -$2.55K | – | 2115 |
|
|
2024
Q4 | $2.55K | Buy |
+21
| New | +$2.55K | ﹤0.01% | 2071 |
|
|
2024
Q2 | – | Sell |
-183
| Closed | -$23.7K | – | 3543 |
|
|
2024
Q1 | $23.7K | Buy |
+183
| New | +$23.7K | ﹤0.01% | 1528 |
|
|
2023
Q4 | – | Sell |
-3,295
| Closed | -$399K | – | 1668 |
|
|
2023
Q3 | $399K | Buy |
3,295
+1,246
| +61% | +$151K | 0.03% | 379 |
|
|
2023
Q2 | $235K | Sell |
2,049
-1,279
| -38% | -$146K | 0.02% | 501 |
|
|
2023
Q1 | $459K | Hold |
3,328
| – | – | 0.03% | 369 |
|
|
2022
Q4 | $431K | Buy |
3,328
+594
| +22% | +$77K | 0.03% | 337 |
|
|
2022
Q3 | $302K | Buy |
+2,734
| New | +$302K | 0.03% | 383 |
|
|
2021
Q1 | – | Sell |
-3,611
| Closed | -$615K | – | 1139 |
|
|
2020
Q4 | $615K | Sell |
3,611
-749
| -17% | -$128K | 0.08% | 222 |
|
|
2020
Q3 | $612K | Buy |
4,360
+800
| +22% | +$112K | 0.09% | 198 |
|
|
2020
Q2 | $570K | Hold |
3,560
| – | – | 0.09% | 207 |
|
|
2020
Q1 | $348K | Buy |
3,560
+280
| +9% | +$27.4K | 0.07% | 249 |
|
|
2019
Q4 | $423K | Hold |
3,280
| – | – | 0.07% | 260 |
|
|
2019
Q3 | $247K | Buy |
3,280
+490
| +18% | +$36.9K | 0.04% | 338 |
|
|
2019
Q2 | $424K | Hold |
2,790
| – | – | 0.08% | 235 |
|
|
2019
Q1 | $332K | Buy |
2,790
+1,180
| +73% | +$140K | 0.07% | 259 |
|
|
2018
Q4 | $175K | Buy |
1,610
+1,010
| +168% | +$110K | 0.04% | 334 |
|
|
2018
Q3 | $97K | Buy |
+600
| New | +$97K | 0.02% | 437 |
|